Kristensen, D T, Øvlisen, A K, Jakobsen, L H, Severinsen, M T, Hannig, L H, Starklint, J, Hilsøe, M H, Vallentin, A P, Brabrand, M, Hasselbalch, H C, El-Galaly, T C & Roug, A S 2023, ' Use of statins and risk of myeloproliferative neoplasms-a Danish nationwide case-control study ', Blood advances . https://doi.org/10.1182/bloodadvances.2023009784
Verstovsek, S, Gerds, A, Vannucchi, A, Vannucchi, A, Al-Ali, H K, Lavie, D, Kuykendall, A T, Grosicki, S, Iurlo, A, Goh, Y T, Lazaroiu, M C, Egyed, M, Fox, M L, McLornan, D, Harrison, C N, Perkins, A, Yoon, S S, Gupta, V, Kiladjian, J J, Granacher, N, Lee, S E, Ocroteala, L, Passamonti, F, Klencke, B J, Ro, S, Donahue, R, Kawashima, J, Mesa, R, MOMENTUM Study Investigators & Severinsen, M T 2023, ' Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM) : results from an international, double-blind, randomised, controlled, phase 3 study ', The Lancet, vol. 401, no. 10373, pp. 269-280 . https://doi.org/10.1016/S0140-6736(22)02036-0
Knudsen, T A, Skov, V, Stevenson, K E, Werner, L, Duke, W, Laurore, C, Gibson, C J, Nag, A, Thorner, A R, Wollison, B, Hansen, D L, Ellervik, C, El Fassi, D, de Stricker, K, Ocias, L F, Brabrand, M, Bjerrum, O W, Overgaard, U, Frederiksen, M, Kristensen, T, Kruse, T, Thomassen, M, Mourits-Andersen, T, Severinsen, M T, Stentoft, J, Starklint, J, Neuberg, D, Kjaer, L, Larsen, T S, Hasselbalch, H C, Lindsley, R C & Mullally, A 2022, ' Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses ', Blood Advances, vol. 6, no. 7, pp. 2107-2119 . https://doi.org/10.1182/bloodadvances.2021004856 Knudsen, T A, Skov, V, Stevenson, K E, Werner, L, Duke, W, Laurore, C, Gibson, C J, Nag, A, Thorner, A R, Wollison, B, Hansen, D L, Ellervik, C, El Fassi, D, de Stricker, K, Ocias, L F, Brabrand, M, Bjerrum, O W, Overgaard, U M, Frederiksen, M, Kristensen, T K, Kruse, T A, Thomassen, M, Mourits-Andersen, T, Severinsen, M T, Stentoft, J, Starklint, J, Neuberg, D S, Kjaer, L, Larsen, T S, Hasselbalch, H C, Lindsley, R C & Mullally, A 2022, ' Genomic Profiling of a Randomized Trial of Interferon-α versus Hydroxyurea in MPN Reveals Mutation-Specific Responses ', Blood advances, vol. 6, no. 7, pp. 2107–2119 . https://doi.org/10.1182/bloodadvances.2021004856 Knudsen, T A, Skov, V, Stevenson, K, Werner, L, Duke, W, Laurore, C, Gibson, C J, Nag, A, Thorner, A R, Wollison, B, Hansen, D L, Ellervik, C, Fassi, D E, de Stricker, K, Ocias, L F, Brabrand, M, Bjerrum, O W, Overgaard, U M, Frederiksen, M, Kristensen, T K, Kruse, T A, Thomassen, M, Mourits-Andersen, T, Severinsen, M T, Stentoft, J, Starklint, J, Neuberg, D S, Kjaer, L, Larsen, T S, Hasselbalch, H C, Lindsley, R C & Mullally, A 2022, ' Genomic profiling of a randomized trial of interferon-a vs hydroxyurea in MPN reveals mutation-specific responses ', Blood advances, vol. 6, no. 7, pp. 2107-2119 . https://doi.org/10.1182/bloodadvances.2021004856 Knudsen, T A, Skov, V, Stevenson, K, Werner, L, Duke, W, Laurore, C, Gibson, C J, Nag, A, Thorner, A R, Wollison, B, Hansen, D L, Ellervik, C, Fassi, D E, de Stricker, K, Ocias, L F, Brabrand, M, Bjerrum, O W, Overgaard, U M, Frederiksen, M, Kristensen, T K, Kruse, T A, Thomassen, M, Mourits-Andersen, T, Severinsen, M T, Stentoft, J, Starklint, J, Neuberg, D S, Kjaer, L, Larsen, T S, Hasselbalch, H C, Lindsley, R C & Mullally, A 2022, ' Genomic profiling of a randomized trial of interferon-a vs hydroxyurea in MPN reveals mutation-specific responses ', Blood Advances, vol. 6, no. 7, pp. 2107-2119 . https://doi.org/10.1182/bloodadvances.2021004856
Brabrand, M, Hansen, K N, Laursen, C B, Larsen, T S, Vestergaard, H & Abildgaard, N 2019, ' Frequency and etiology of pulmonary hypertension in patients with myeloproliferative neoplasms ', European Journal of Haematology, vol. 102, no. 3, pp. 227-234 . https://doi.org/10.1111/ejh.13197
Cancers Brabrand, M & Frederiksen, H 2020, ' Risks of solid and lymphoid malignancies in patients with myeloproliferative neoplasms : Clinical implications ', Cancers, vol. 12, no. 10, 3061 . https://doi.org/10.3390/cancers12103061 Cancers, Vol 12, Iss 3061, p 3061 (2020)
Risum, M, Helweg-Larsen, J, Petersen, S L, Kampmann, P, Overgaard, U M, Fassi, D E, Nielsen, O J, Brabrand, M, Rubek, N, Munksgaard, L, Severinsen, M T, Nielsen, B, Gertsen, J B, Gylfe, Å, Hjort, U, Vourtsi, A, Hare, R K & Arendrup, M C 2020, ' Introduction of a comprehensive diagnostic and interdisciplinary management approach in haematological patients with mucormycosis : A pre and post-intervention analysis ', Journal of Fungi, vol. 6, no. 4, 268, pp. 1-16 . https://doi.org/10.3390/jof6040268 Risum, M, Helweg-Larsen, J, Petersen, S L, Kampmann, P, Overgaard, U M, Fassi, D E, Nielsen, O J, Brabrand, M, Rubek, N, Munksgaard, L, Severinsen, M T, Nielsen, B, Gertsen, J B, Gylfe, Å, Hjort, U, Vourtsi, A, Hare, R K & Arendrup, M C 2020, ' Introduction of a comprehensive diagnostic and interdisciplinary management approach in haematological patients with mucormycosis : A pre and post-intervention analysis ', Journal of Fungi, vol. 6, no. 4, 268 . https://doi.org/10.3390/jof6040268 Journal of Fungi Volume 6 Issue 4 Journal of Fungi, Vol 6, Iss 268, p 268 (2020) Risum, M, Helweg-Larsen, J, Petersen, S L, Kampmann, P, Overgaard, U M, El Fassi, D, Nielsen, O J, Brabrand, M, Rubek, N, Munksgaard, L, Severinsen, M T, Nielsen, B, Gertsen, J B, Gylfe, Å, Hjort, U, Vourtsi, A, Hare, R K & Arendrup, M C 2020, ' Introduction of a Comprehensive Diagnostic and Interdisciplinary Management Approach in Haematological Patients with Mucormycosis : A Pre and Post-Intervention Analysis ', Journal of fungi (Basel, Switzerland), vol. 6, no. 4, 268, pp. 1-16 . https://doi.org/10.3390/jof6040268
Knudsen, T A, Hansen, D L, Ocias, L F, Bjerrum, O W, Brabrand, M, El Fassi, D, Frederiksen, M, Kjaer, L, Kristensen, T K, Kruse, T A, Mourits-Andersen, T, Moller, P, Overgaard, U M, Severinsen, M T, Skov, V, Stentoft, J, Starklint, J, de Stricker, K, Thomassen, M, Larsen, T S & Hasselbalch, H C 2018, ' Long-Term Efficacy and Safety of Recombinant Interferon Alpha-2 Vs. Hydroxyurea in Polycythemia Vera: Preliminary Results from the Three-Year Analysis of the Daliah Trial-a Randomized Controlled Phase III Clinical Trial ', Blood, vol. 132, no. 1 . https://doi.org/10.1182/blood-2018-99-111255 Knudsen, T A, Hansen, D L, Ocias, L F, Bjerrum, O W, Brabrand, M, El Fassi, D, Frederiksen, M, Kjær, L, Kristensen, T K, Kruse, T A, Mourits-Andersen, T, Møller, P, Overgaard, U M, Severinsen, M T, Skov, V, Stentoft, J, Starklint, J, de Stricker, K, Thomassen, M, Larsen, T S & Hasselbalch, H C 2018, ' Long-Term Efficacy and Safety of Recombinant Interferon Alpha-2 Vs. Hydroxyurea in Polycythemia Vera : Preliminary Results from the Three-Year Analysis of the Daliah Trial-a Randomized Controlled Phase III Clinical Trial ', Blood, vol. 132, no. Suppl 1, pp. 580 . https://doi.org/10.1182/blood-2018-99-111255
Knudsen, T A, Skov, V, Werner, L, Duke, W, Gibson, C J, Nag, A, Thorner, A R, Wollison, B, Lund Hansen, D, Larsen, T S, Ellervik, C, El Fassi, D, de Stricker, K, Ocias, L F, Brabrand, M, Weiss Bjerrum, O, Overgaard, U M, Frederiksen, M, Kielsgaard Kristensen, T, Kruse, T A, Thomassen, M, Mourits-Andersen, H T, Severinsen, M T, Jesper, S, Starklint, J, Møller, P, Neuberg, D S, Kjær, L, Hasselbalch, H C, Coleman Lindsley, R & Mullally, A 2019, ' Genomic Profiling of a Phase III Clinical Trial of Interferon Versus Hydroxyurea in MPN Patients Reveals Mutation-Specific and Treatment-Specific Patterns of Response ', Blood, vol. 134, no. Supplement 1, 4202 . https://doi.org/10.1182/blood-2019-126164 Knudsen, T A, Skov, V, Werner, L, Duke, W, Gibson, C J, Nag, A, Thorner, A R, Wollison, B, Lund Hansen, D, Larsen, T S, Ellervik, C, El Fassi, D, de Stricker, K, Ocias, L F, Brabrand, M, Weiss Bjerrum, O, Overgaard, U M, Frederiksen, M, Kielsgaard Kristensen, T, Kruse, T A, Thomassen, M, Mourits-Andersen, T, Severinsen, M T, Jesper, S, Starklint, J, Møller, P, Neuberg, D S, Kjær, L, Hasselbalch, H C, Coleman Lindsley, R & Mullally, A 2019, ' Genomic Profiling of a Phase III Clinical Trial of Interferon Versus Hydroxyurea in MPN Patients Reveals Mutation-Specific and Treatment-Specific Patterns of Response ', American Society of Hematology: 61st Annual Meeting (ASH), Orlando, United States, 07/12/2019-10/12/2019 . < https://ashpublications.org/blood/article/134/Supplement_1/4202/425637/Genomic-Profiling-of-a-Phase-III-Clinical-Trial-of >